|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Amyl nitrite#Contraindications]] |
| {{Amyl nitrite}}
| |
| {{CMG}}; {{AE}} {{PB}}
| |
| | |
| | |
| ==Contraindications==
| |
| | |
| Since it may increase intraocular and intracranial pressures, amyl nitrite is contraindicated or should be used with great caution in patients with [[glaucoma]], recent [[head trauma]] or [[cerebral hemorrhage]]. Amyl nitrite can cause harm to the fetus when it is administered to a pregnant woman because it significantly reduces systemic blood pressure and blood flow on the maternal side of the placenta.
| |
| | |
| ===Carcinogenesis, Mutagenesis, Fertility Impairment===
| |
| | |
| Adequate long term studies to establish adverse carcinogenic potential of this drug have not been reported.
| |
| | |
| ===Pregnancy===
| |
| | |
| Teratogenic effects. Category C. Animal studies have not been conducted with amyl nitrite. It is also not known whether amyl nitrite can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Amyl nitrite should be given to a pregnant woman only if clearly needed.
| |
| | |
| ===Nursing Mothers===
| |
| | |
| It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when amyl nitrite is administered to a nursing woman.
| |
| | |
| ===Pediatric Use===
| |
| | |
| Safety and effectiveness in children have not been established.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AMYL NITRITE INHALANT [JAMES ALEXANDER CORPORATION] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c1b6e536-df5f-4f76-8e3c-6dc2f1e9975e | publisher = | date = | accessdate = 30 January 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Drugs]]
| |